A Comparison of the Pharmacokinetics and Pharmacodynamics of Pregabalin and Gabapentin

被引:0
|
作者
Howard N. Bockbrader
David Wesche
Raymond Miller
Sunny Chapel
Nancy Janiczek
Paula Burger
机构
[1] Pfizer Global Research & Development,
[2] Pfizer Global Research & Development,undefined
来源
Clinical Pharmacokinetics | 2010年 / 49卷
关键词
Neuropathic Pain; Gabapentin; Pregabalin; Postherpetic Neuralgia; Pain Score Reduction;
D O I
暂无
中图分类号
学科分类号
摘要
Pregabalin and gabapentin share a similar mechanism of action, inhibiting calcium influx and subsequent release of excitatory neurotransmitters; however, the compounds differ in their pharmacokinetic and pharmacodynamic characteristics. Gabapentin is absorbed slowly after oral administration, with maximum plasma concentrations attained within 3–4 hours. Orally administered gabapentin exhibits saturable absorption — a nonlinear (zero-order) process — making its pharmacokinetics less predictable. Plasma concentrations of gabapentin do not increase proportionally with increasing dose. In contrast, orally administered pregabalin is absorbed more rapidly, with maximum plasma concentrations attained within 1 hour. Absorption is linear (first order), with plasma concentrations increasing proportionately with increasing dose. The absolute bioavailability of gabapentin drops from 60% to 33% as the dosage increases from 900 to 3600 mg/day, while the absolute bioavailability of pregabalin remains at <-90% irrespective ofthe dosage. Both drugs can be given without regard to meals. Neither drug binds to plasma proteins. Neither drug is metabolized by nor inhibits hepatic enzymes that are responsible for the metabolism of other drugs. Both drugs are excreted renally, with elimination half-lives of approximately 6 hours.
引用
收藏
页码:661 / 669
页数:8
相关论文
共 50 条
  • [1] A Comparison of the Pharmacokinetics and Pharmacodynamics of Pregabalin and Gabapentin
    Bockbrader, Howard N.
    Wesche, David
    Miller, Raymond
    Chapel, Sunny
    Janiczek, Nancy
    Burger, Paula
    CLINICAL PHARMACOKINETICS, 2010, 49 (10) : 661 - 669
  • [2] Pharmacodynamic comparison of pregabalin and gabapentin
    Miller, R.
    Bockbrader, H.
    Chapel, S.
    Barrett, J. A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 108 - 108
  • [3] Pharmacodynamic comparison of pregabalin and gabapentin
    Miller, R
    Bockbrader, H
    Chapel, S
    Barrett, JA
    NEUROLOGY, 2006, 66 (05) : A37 - A37
  • [4] Pharmacodynamic comparison of pregabalin and gabapentin
    Bockbrader, H.
    Miller, R.
    Chapel, S.
    Barrett, J.
    EPILEPSIA, 2006, 47 : 142 - 143
  • [5] Population Pharmacokinetics and Pharmacodynamics of Gabapentin After Administration of Gabapentin Enacarbil
    Lal, Ritu
    Sukbuntherng, Juthamas
    Luo, Wendy
    Tovera, James
    Lassauzet, Marie Liesse
    Cundy, Kenneth C.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (01): : 29 - 40
  • [6] Pharmacokinetics and pharmacodynamics of repeat dosing of gabapentin in adult horses
    Gold, Jenifer R.
    Grubb, Tamera L.
    Cox, Sherry
    Malavasi, Lais
    Villarino, Nicholas L.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2022, 36 (02) : 792 - 797
  • [7] PREGABALIN AND GABAPENTIN Misuse of gabapentin and pregabalin may be underestimated
    Nahar, Limon K.
    Andrews, Rebecca
    Murphy, Kevin G.
    Paterson, Sue
    BMJ-BRITISH MEDICAL JOURNAL, 2017, 359
  • [8] A Comparison of Pregabalin and Gabapentin in Palliative Care #289
    Pruskowski, Jennifer
    Arnold, Robert M.
    JOURNAL OF PALLIATIVE MEDICINE, 2015, 18 (04) : 386 - 387
  • [9] Pregabalin in the treatment of primary orthostatic tremor: A comparison with gabapentin
    Rodrigues, J.
    Edwards, D.
    Walters, S. E.
    Needham, K.
    Thickbroom, G.
    Stell, R.
    Mastaglia, F. L.
    MOVEMENT DISORDERS, 2006, 21 : S700 - S700
  • [10] Comparison of the effects of gabapentin and pregabalin on wound healing in rats
    Saritas, Tuba Berra
    Korkmaz, Musa
    Sevimli, Alper
    Saritas, Zulfikar Kadir
    INTERNATIONAL WOUND JOURNAL, 2016, 13 (05) : 748 - 753